We are live on ! Find out more
FO

FT Options Portfolio holdings

AUM $66.4M
1-Year Est. Return 18.48%
This Fund
S&P 500
This Quarter Est. Return
+8.72%
1 Year Est. Return
+18.48%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$58.1M
AUM Growth
-$17.9M
Cap. Flow
-$4.42M
Cap. Flow %
-7.61%
Top 10 Hldgs %
43.93%
Holding
340
New
63
Increased
59
Reduced
56
Closed
151

Sector Composition

1 Healthcare 37.51%
2 Consumer Staples 17.11%
3 Consumer Discretionary 2.69%
4 Communication Services 1.36%
5 Materials 1.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TIME
326
CALL
DELISTED
Time Inc.
TIME
-20,400
Closed -$12K
KITE
327
PUT
DELISTED
Kite Pharma, Inc.
KITE
-64,900
Closed -$66K
DD
328
CALL
DELISTED
Du Pont De Nemours E I
DD
-140,400
Closed -$677K
DD
329
PUT
DELISTED
Du Pont De Nemours E I
DD
-14,000
Closed -$15K
PNRA
330
CALL
DELISTED
Panera Bread Co
PNRA
-21,200
Closed -$280K
PNRA
331
PUT
DELISTED
Panera Bread Co
PNRA
-14,000
Closed -$15K
YHOO
332
DELISTED
Yahoo Inc
YHOO
-10,000
Closed -$464K
EBIX
333
CALL
DELISTED
Ebix Inc
EBIX
-1,300
Closed -$2K
EBIX
334
DELISTED
Ebix Inc
EBIX
-7,335
Closed -$449K
EBIX
335
PUT
DELISTED
Ebix Inc
EBIX
-23,500
Closed -$14K
CELG
336
CALL
DELISTED
Celgene Corp
CELG
-43,500
Closed -$285K
LJPC
337
CALL
DELISTED
La Jolla Pharmaceutical Company
LJPC
-21,600
Closed -$6K
LJPC
338
DELISTED
La Jolla Pharmaceutical Company
LJPC
-33,141
Closed -$989K
LJPC
339
PUT
DELISTED
La Jolla Pharmaceutical Company
LJPC
-37,800
Closed -$66K
AZPN
340
CALL
DELISTED
ASPEN TECHNOLOGY INC
AZPN
-7,300
Closed -$31K

Similar funds

FT Options's Q2 2017 Portfolio in Review

As of Q2 2017, FT Options held 340 positions worth $58.1M, down 24% from $76M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

FT Options withdrew a net $4.42M in Q2 2017, closing 151 positions and reducing 56 holdings. Its most notable exit was Foot Locker, an estimated $2.12M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 35% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

Against the trend, FT Options opened a new position in Amgen worth $2.08M.

  • FT Options's largest Q2 2017 buy was Amgen: 12,082 shares worth $2.08M.
  • FT Options added most to Clovis Oncology, Inc. in Q2 2017, an estimated $2.31M increase.
  • FT Options's biggest Q2 2017 reduction was Abbott, cutting an estimated $5.02M.
  • FT Options fully exited Foot Locker in Q2 2017, selling an estimated $2.12M.
  • FT Options's ten largest holdings make up 44% of its $58.1M portfolio in Q2 2017.
  • FT Options opened 63 new positions and closed 151 in Q2 2017.
  • FT Options's portfolio value fell 24% quarter-over-quarter to $58.1M.

Based on FT Options's 13F filing for Q2 2017, filed 11 Aug 2017.